Ida K. Lund - Recent Publications

Lund IK, Nielsen BS, Almholt K, Rønø B, Hald A, Illemann M, Green KA, Christensen IJ, Rømer J, Lund LR.:
Concomitant lack of MMP9 and uPA disturbs physiological tissue remodeling.
Dev Biol. 2011 Oct 1;358(1):56-67.

I.K. Lund, M. Illemann, T. Thurison, I.J. Christensen, and G. Høyer-Hansen:
uPAR as anti-cancer target: evaluation of biomarker potential, histological localization, and antibody-based therapy.
Review accepted for publication in Current Drug Targets, The urokinase plasminogen activation system in pathology: use in prognosis and therapy. 2011.

A. Jögi, B. Rønø, I.K. Lund, B. S. Nielsen, M. Ploug et al.:
Neutralisation of uPA with a monoclonal antibody reduces plasmin formation and delays skin wound healing in tPA-deficient mice.
PLoS. ONE., 2010; 5: e12746.

M.G. Rasch, I.K. Lund, M. Illemann, G. Høyer-Hansen, and H. Gårdsvoll:
Purification and characterization of recombinant full-length and protease domain of murine MMP-9 expressed in Drosophila S2 cells.
Protein Expression and Purification, 2010; 72: 87-94.

T. Thurison, A.F. Lomholt, M.G. Rasch, I.K. Lund, H. J. Nielsen et al.:
A New Assay for Measurement of the Liberated Domain I of the Urokinase Receptor in Plasma Improves the Prediction of Survival in Colorectal Cancer.
Clin. Chem., 2010; 56: 1636-1640.

I.K. Lund, A. Jögi, B. Rønø, M.G. Rasch, L.R. Lund et al.:
Antibody-mediated targeting of the urokinase-type plasminogen activator proteolytic function neutralizes fibrinolysis in vivo.
J. Biol. Chem., 2008; 283: 32506-32515.

M.G. Rasch, I.K. Lund, C.E. Almasi, and G. Høyer-Hansen:
Intact and cleaved uPAR forms: diagnostic and prognostic value in cancer.
Front Biosci., 2008; 13: 6752-6762.

M.G. Rasch, J. Pass, M. Illemann, G. Høyer-Hansen, and I. K. Lund:
Discrimination of different forms of the murine urokinase plasminogen activator receptor on the cell surface using monoclonal antibodies.
J Immunol Methods, 2008; 339: 55-65.

G. Høyer-Hansen and I.K. Lund:
Urokinase receptor variants in tissue and body fluids.
Adv. Clin. Chem., 2007; 44: 65-102.

J. Pass, A. Jögi, I.K. Lund, B. Rønø, M.G. Rasch et al.:
Murine monoclonal antibodies against murine uPA receptor produced in gene-deficient mice: Inhibitory effects on receptor-mediated uPA activity in vitro and in vivo.
Thromb. Haemostt., 2007; 97: 1013-1022.

I.K. Lund, J.A. Hansen, H.S. Andersen, N.P. Møller, and N. Billestrup:
Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling.
J Mol Endocrinol., 2005; 34: 339-351.

I.K. Lund, H.S. Andersen, L.F. Iversen, O.H. Olsen, K. B. Møller et al.:
Structure-based design of selective and potent inhibitors of protein-tyrosine phosphatase beta.
J. Biol. Chem., 2004; 279: 24226-24235.